在IgA病的管理新兴的观点:一个全面的审查
Ana Marta Gomes1,2, Bruno Schau3, Ana Farinha4
1Nephrology Department, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
Porto biomedical journal
|November 15, 2024
概括
一种常见的脏疾病IgA脏病 (IgAN) 正在通过新疗法和生物标志物重新评估. 研究正在推进对IGAN患者的理解和治疗选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
背景情况:
- IgA脏病 (IgAN) 是全球最常见的原发性淋巴细胞炎,导致慢性病和功能衰竭.
- 由于银河糖缺乏IgA和C3的质沉积的特征,目前的治疗依赖于支持性护理,而皮质类固醇的疗效仍在争论中.
- 许多患者对现有治疗没有反应,需要脏替代疗法,并影响生活质量.
研究的目的:
- 审查有关IgA脏病 (IgAN) 病理生理学的当前知识.
- 讨论当前的疾病管理策略及其局限性.
- 突出IGAN研究中的新兴进展和创新的治疗选择.
主要方法:
- 对IgA病 (IgAN) 当前文献的综述.
- 对正在进行的国际临床试验和治疗发展进行分析.
- 讨论 IgAN 查和监测的新型非侵入性生物标志物.
主要成果:
- 目前正在进行的多项临床试验正在探索Igan的新疗法,包括SGLT2抑制剂,双受体抑制剂和补充抑制剂.
- 人们对开发用于Igan查,风险分层和治疗反应监测的非侵入性生物标志物越来越感兴趣.
- 有证据表明,可能会对Igan管理指南进行即将修订.
结论:
- 伊干细胞的研究正在迅速发展,在了解病理生理学和开发创新治疗方面取得了重大进展.
- 新的治疗药物和非侵入性生物标志物有望改善Igan的管理和患者的治疗结果.
- 国际合作对于推进IGAN研究和临床翻译至关重要.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
114
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
114
Open Angle Glaucoma: Treatment
393
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
393
Diabetes: Management and Pharmacotherapy
236
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
236
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
319
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
319
Gastritis III: Clinical Manifestations and Management
158
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
158
Acute Pancreatitis II: Clinical Manifestations and Management
93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93


